COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:

Search Results

One moment please while the data are loaded...
View results
  • Organ: Liver
  • Level of Evidence: Positive, Clear Evidence, Some Evidence
Displays results that match exactly with the given criteria.
Exact Match Publication No. CASRN Test Article Name Species Sex Route Organ Level of Evidence Tumor Type/Incidence Finding Type
Yes TR-000 (143-50-0) 143-50-0 Chlordecone (kepone) Mice Female Dosed-Feed Liver Positive CARCINOMA; HYPERPLASIA Neoplastic Lesions
Yes TR-000 (143-50-0) 143-50-0 Chlordecone (kepone) Mice Male Dosed-Feed Liver Positive CARCINOMA; HYPERPLASIA Neoplastic Lesions
Yes TR-000 (143-50-0) 143-50-0 Chlordecone (kepone) Rats Female Dosed-Feed Liver Positive CARCINOMA; HYPERPLASIA Neoplastic Lesions
Yes TR-000 (143-50-0) 143-50-0 Chlordecone (kepone) Rats Male Dosed-Feed Liver Positive CARCINOMA; HYPERPLASIA Neoplastic Lesions
Yes TR-000 (67-66-3) 67-66-3 Chloroform Mice Female Gavage Liver Positive CARCINOMA Neoplastic Lesions
Yes TR-000 (67-66-3) 67-66-3 Chloroform Mice Male Gavage Liver Positive CARCINOMA Neoplastic Lesions
Yes TR-002 79-01-6 Trichloroethylene Mice Female Gavage Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-002 79-01-6 Trichloroethylene Mice Male Gavage Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-008 57-74-9 Chlordane (analytical grade) Mice Female Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-008 57-74-9 Chlordane (analytical grade) Mice Male Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-009 76-44-8 Heptachlor Mice Female Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-009 76-44-8 Heptachlor Mice Male Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-013 127-18-4 Tetrachloroethylene Mice Female Gavage Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-013 127-18-4 Tetrachloroethylene Mice Male Gavage Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-021 309-00-2 Aldrin Mice Male Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-025 133-90-4 Chloramben Mice Female Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-026 1836-75-5 Nitrofen Mice Female Dosed-Feed Liver Positive HEPATOCELLULAR CARCINOMA Neoplastic Lesions
Yes TR-026 1836-75-5 Nitrofen Mice Male Dosed-Feed Liver Positive HEPATOCELLULAR CARCINOMA Neoplastic Lesions
Yes TR-027 79-34-5 1,1,2,2-Tetrachloroethane Mice Female Gavage Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-027 79-34-5 1,1,2,2-Tetrachloroethane Mice Male Gavage Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-029 129-15-7 2-Methyl-1-nitroanthraquinone Rats Female Dosed-Feed Liver Positive (NEOPLASTIC NODULE OR CARCINOMA) Neoplastic Lesions
Yes TR-029 129-15-7 2-Methyl-1-nitroanthraquinone Rats Male Dosed-Feed Liver Positive (NEOPLASTIC NODULE, CARCINOMA) Neoplastic Lesions
Yes TR-033 961-11-5 Tetrachlorvinphos Mice Female Dosed-Feed Liver Positive (NEOPLASTIC NODULE) Neoplastic Lesions
Yes TR-033 961-11-5 Tetrachlorvinphos Mice Male Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-080 123-91-1 1,4-Dioxane Mice Male Dosed-Water Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-080 123-91-1 1,4-Dioxane Rats Female Dosed-Water Liver Positive (ADENOMA) Neoplastic Lesions
Yes TR-085 5131-60-2 4-Chloro-m-phenylenediamine Mice Female Dosed-Feed Liver Positive (ADENOMA OR CARCINOMA) Neoplastic Lesions
Yes TR-086 106-93-4 1,2-Dibromoethane Rats Female Gavage Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-099 136-40-3 Phenazopyridine hydrochloride Mice Female Dosed-Feed Liver Positive (ADENOMA, CARCINOMA) Neoplastic Lesions
Yes TR-100 135-20-6 Cupferron Mice Female Dosed-Feed Liver Positive CARCINOMA Neoplastic Lesions
Yes TR-100 135-20-6 Cupferron Rats Female Dosed-Feed Liver Positive CARCINOMA Neoplastic Lesions
Yes TR-100 135-20-6 Cupferron Rats Male Dosed-Feed Liver Positive CARCINOMA Neoplastic Lesions
Yes TR-090 115-32-2 Dicofol Mice Male Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-092 122-66-7 Hydrazobenzene Mice Female Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-092 122-66-7 Hydrazobenzene Rats Female Dosed-Feed Liver Positive (NEOPLASTIC NODULE) Neoplastic Lesions
Yes TR-092 122-66-7 Hydrazobenzene Rats Male Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-093 6109-97-3 3-Amino-9-ethylcarbazole HCl Mice Female Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-093 6109-97-3 3-Amino-9-ethylcarbazole HCl Mice Male Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-093 6109-97-3 3-Amino-9-ethylcarbazole HCl Rats Female Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-093 6109-97-3 3-Amino-9-ethylcarbazole HCl Rats Male Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-034 1582-09-8 Trifluralin Mice Female Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-037 8001-35-2 Toxaphene Mice Female Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-037 8001-35-2 Toxaphene Mice Male Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-039 303-34-4 Lasiocarpine Rats Female Dosed-Feed Liver Positive Angiosarcoma, carcinoma, adenoma Neoplastic Lesions
Yes TR-039 303-34-4 Lasiocarpine Rats Male Dosed-Feed Liver Positive Angiosarcoma, carcinoma, adenoma Neoplastic Lesions
Yes TR-047 139-65-1 4,4'-Thiodianiline Mice Female Dosed-Feed Liver Positive CARCINOMA Neoplastic Lesions
Yes TR-047 139-65-1 4,4'-Thiodianiline Mice Male Dosed-Feed Liver Positive CARCINOMA Neoplastic Lesions
Yes TR-047 139-65-1 4,4'-Thiodianiline Rats Male Dosed-Feed Liver Positive CARCINOMA Neoplastic Lesions
Yes TR-063 95-83-0 4-Chloro-o-phenylenediamine Mice Female Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-063 95-83-0 4-Chloro-o-phenylenediamine Mice Male Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-068 67-72-1 Hexachloroethane Mice Female Gavage Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-068 67-72-1 Hexachloroethane Mice Male Gavage Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-074 79-00-5 1,1,2-Trichloroethane Mice Female Gavage Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-074 79-00-5 1,1,2-Trichloroethane Mice Male Gavage Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-075 510-15-6 Chlorobenzilate Mice Female Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-075 510-15-6 Chlorobenzilate Mice Male Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-076 126-72-7 tris(2,3-Dibromopropyl) phosphate Mice Female Dosed-Feed Liver Positive (ADENOMA, CARCINOMA) Neoplastic Lesions
Yes TR-080 123-91-1 1,4-Dioxane Mice Female Dosed-Water Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-117 94-52-0 6-Nitrobenzimidazole Mice Female Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-117 94-52-0 6-Nitrobenzimidazole Mice Male Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-118 602-87-9 5-Nitroacenaphthene Mice Female Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-124 120-62-7 Piperonyl sulfoxide Mice Male Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-127 99-59-2 5-Nitro-o-anisidine Mice Female Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-131 72-55-9 p,p'-Dichlorodiphenyl dichloroethylene Mice Female Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-131 72-55-9 p,p'-Dichlorodiphenyl dichloroethylene Mice Male Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-133 1777-84-0 3-Nitro-p-acetophenetide Mice Male Dosed-Feed Liver Positive (ADENOMA OR CARCINOMA) Neoplastic Lesions
Yes TR-142 120-71-8 p-Cresidine Mice Female Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-142 120-71-8 p-Cresidine Rats Male Dosed-Feed Liver Positive (NEOPLASTIC NODULE OR CARCINOMA) Neoplastic Lesions
Yes TR-143 2243-62-1 1,5-Naphthalenediamine Mice Female Dosed-Feed Liver Positive (ADENOMA, CARCINOMA) Neoplastic Lesions
Yes TR-144 117-79-3 2-Aminoanthraquinone Mice Female Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-144 117-79-3 2-Aminoanthraquinone Mice Male Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-144 117-79-3 2-Aminoanthraquinone Rats Male Dosed-Feed Liver Positive (NEOPLASTIC NODULE OR CARCINOMA) Neoplastic Lesions
Yes TR-146 139-94-6 Nithiazide Mice Male Dosed-Feed Liver Positive (ADENOMA OR CARCINOMA) Neoplastic Lesions
Yes TR-153 636-21-5 o-Toluidine hydrochloride Mice Female Dosed-Feed Liver Positive (ADENOMA OR CARCINOMA) Neoplastic Lesions
Yes TR-155 88-06-2 2,4,6-Trichlorophenol Mice Female Dosed-Feed Liver Positive (ADENOMA, CARCINOMA) Neoplastic Lesions
Yes TR-155 88-06-2 2,4,6-Trichlorophenol Mice Male Dosed-Feed Liver Positive (ADENOMA, CARCINOMA) Neoplastic Lesions
Yes TR-160 137-17-7 2,4,5-Trimethylaniline Mice Female Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-160 137-17-7 2,4,5-Trimethylaniline Rats Female Dosed-Feed Liver Positive (NEOPLASTIC NODULE, CARCINOMA) Neoplastic Lesions
Yes TR-160 137-17-7 2,4,5-Trimethylaniline Rats Male Dosed-Feed Liver Positive (NEOPLASTIC NODULE, CARCINOMA) Neoplastic Lesions
Yes TR-162 95-80-7 2,4-Diaminotoluene (2,4-toluene diamine) Mice Female Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-162 95-80-7 2,4-Diaminotoluene (2,4-toluene diamine) Rats Female Dosed-Feed Liver Positive (NEOPLASTIC NODULE, CARCINOMA) Neoplastic Lesions
Yes TR-162 95-80-7 2,4-Diaminotoluene (2,4-toluene diamine) Rats Male Dosed-Feed Liver Positive (NEOPLASTIC NODULE, CARCINOMA) Neoplastic Lesions
Yes TR-169 5307-14-2 2-Nitro-p-phenylenediamine Mice Female Dosed-Feed Liver Positive (ADENOMA) Neoplastic Lesions
Yes TR-181 90-94-8 Michler's ketone Mice Female Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-181 90-94-8 Michler's ketone Rats Female Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-181 90-94-8 Michler's ketone Rats Male Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-184 1836-75-5 Nitrofen Mice Female Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-184 1836-75-5 Nitrofen Mice Male Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-186 101-61-1 4,4'-Methylenebis(N,N-dimethyl)benzenamine Mice Female Dosed-Feed Liver Positive (ADENOMA OR CARCINOMA) Neoplastic Lesions
Yes TR-187 95-79-4 5-Chloro-o-toluidine Mice Female Dosed-Feed Liver Positive CARCINOMA Neoplastic Lesions
Yes TR-187 95-79-4 5-Chloro-o-toluidine Mice Male Dosed-Feed Liver Positive CARCINOMA Neoplastic Lesions
Yes TR-107 99-55-8 5-Nitro-o-toluidine Mice Female Dosed-Feed Liver Positive CARCINOMA Neoplastic Lesions
Yes TR-107 99-55-8 5-Nitro-o-toluidine Mice Male Dosed-Feed Liver Positive CARCINOMA Neoplastic Lesions
Yes TR-108 1937-37-7 C.I. Direct black 38 Rats Female Dosed-Feed Liver Positive Carcinoma, neoplastic nodules Neoplastic Lesions
Yes TR-108 1937-37-7 C.I. Direct black 38 Rats Male Dosed-Feed Liver Positive Carcinoma, neoplastic nodules Neoplastic Lesions
Yes TR-108 2602-46-2 C.I. Direct blue 6 Rats Female Dosed-Feed Liver Positive Carcinoma, neoplastic nodules Neoplastic Lesions
Yes TR-108 2602-46-2 C.I. Direct blue 6 Rats Male Dosed-Feed Liver Positive Carcinoma, neoplastic nodules Neoplastic Lesions
Yes TR-108 16071-86-6 C.I. Direct brown 95 Rats Female Dosed-Feed Liver Positive Carcinoma, neoplastic nodules Neoplastic Lesions
Yes TR-111 82-28-0 1-Amino-2-methylanthraquinone Mice Female Dosed-Feed Liver Positive (NEOPLASTIC NODULE OR CARCINOMA) Neoplastic Lesions
Yes TR-111 82-28-0 1-Amino-2-methylanthraquinone Rats Female Dosed-Feed Liver Positive (NEOPLASTIC NODULE, CARCINOMA) Neoplastic Lesions
Yes TR-111 82-28-0 1-Amino-2-methylanthraquinone Rats Male Dosed-Feed Liver Positive (NEOPLASTIC NODULE, CARCINOMA) Neoplastic Lesions
Yes TR-205 101-80-4 4,4'-Oxydianiline Mice Female Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-205 101-80-4 4,4'-Oxydianiline Mice Male Dosed-Feed Liver Positive (ADENOMA OR CARCINOMA) Neoplastic Lesions
Yes TR-205 101-80-4 4,4'-Oxydianiline Rats Female Dosed-Feed Liver Positive (NEOPLASTIC NODULE, CARCINOMA) Neoplastic Lesions
Yes TR-205 101-80-4 4,4'-Oxydianiline Rats Male Dosed-Feed Liver Positive (NEOPLASTIC NODULE, CARCINOMA) Neoplastic Lesions
Yes TR-209 1746-01-6 2,3,7,8-Tetrachlorodibenzo-p-dioxin Mice Female Gavage Liver Positive CARCINOMA 1/73 2/50 2/48 6/47 Neoplastic Lesions
Yes TR-209 1746-01-6 2,3,7,8-Tetrachlorodibenzo-p-dioxin Mice Male Gavage Liver Positive CARCINOMA 8/73 9/49 8/49 17/50 Neoplastic Lesions
Yes TR-209 1746-01-6 2,3,7,8-Tetrachlorodibenzo-p-dioxin Rats Female Gavage Liver Positive NEOPLASTIC NODULE 5/75 1/49 3/50 12/49 Neoplastic Lesions
Yes TR-212 103-23-1 Di(2-ethylhexyl)adipate Mice Female Dosed-Feed Liver Positive CARCINOMA 1/50 14/50 12/49 Neoplastic Lesions
Yes TR-212 103-23-1 Di(2-ethylhexyl)adipate Mice Male Dosed-Feed Liver Positive ADENOMA 6/50 8/49 15/49 Neoplastic Lesions
Yes TR-216 2432-99-7 11-Aminoundecanoic acid Rats Male Dosed-Feed Liver Positive NEOPLASTIC NODULE 1/50 9/50 8/50 Neoplastic Lesions
Yes TR-217 117-81-7 Di(2-ethylhexyl) phthalate Mice Female Dosed-Feed Liver Positive CARCINOMA 0/50 7/50 17/50 Neoplastic Lesions
Yes TR-217 117-81-7 Di(2-ethylhexyl) phthalate Mice Male Dosed-Feed Liver Positive CARCINOMA 9/50 14/48 19/50 Neoplastic Lesions
Yes TR-217 117-81-7 Di(2-ethylhexyl) phthalate Rats Female Dosed-Feed Liver Positive CARCINOMA 0/50 2/49 8/50 Neoplastic Lesions
Yes TR-217 117-81-7 Di(2-ethylhexyl) phthalate Rats Male Dosed-Feed Liver Positive NEOPLASTIC NODULE 2/50 5/49 7/49 OR CARCINOMA 1/50 1/49 5/49 COMBINED 3/50 6/49 12/49 Neoplastic Lesions
Yes TR-219 609-20-1 2,6-Dichloro-p-phenylenediamine Mice Female Dosed-Feed Liver Positive ADENOMA 4/50 4/50 9/50 OR CARCINOMA 2/50 2/50 7/50 Neoplastic Lesions
Yes TR-219 609-20-1 2,6-Dichloro-p-phenylenediamine Mice Male Dosed-Feed Liver Positive ADENOMA 4/50 7/50 15/50 Neoplastic Lesions
Yes TR-222 2832-40-8 C.I. Disperse yellow 3 Mice Female Dosed-Feed Liver Positive ADENOMA 0/50 6/50 12/50 Neoplastic Lesions
Yes TR-222 2832-40-8 C.I. Disperse yellow 3 Rats Male Dosed-Feed Liver Positive NEOPLASTIC NODULE 1/49 15/50 10/50 Neoplastic Lesions
Yes TR-225 5160-02-1 D & C red no. 9 Rats Male Dosed-Feed Liver Positive NEOPLASTIC NODULE 0/50 6/50 7/49 Neoplastic Lesions
Yes TR-226 842-07-9 C.I. Solvent yellow 14 Rats Female Dosed-Feed Liver Positive NEOPLASTIC NODULE 2/50 3/49 10/48 Neoplastic Lesions
Yes TR-226 842-07-9 C.I. Solvent yellow 14 Rats Male Dosed-Feed Liver Positive NEOPLASTIC NODULE 5/50 10/50 30/50 Neoplastic Lesions
Yes TR-232 76-01-7 Pentachloroethane Mice Female Gavage Liver Positive ADENOMA 2/46 8/42 19/45; CARCINOMA 1/46 28/42 13/45 Neoplastic Lesions
Yes TR-232 76-01-7 Pentachloroethane Mice Male Gavage Liver Positive CARCINOMA 4/48 26/44 7/45 Neoplastic Lesions
Yes TR-235 17924-92-4 Zearalenone Mice Female Dosed-Feed Liver Positive ADENOMA 0/50 2/49 7/49 Neoplastic Lesions
Yes TR-237 630-20-6 1,1,1,2-Tetrachloroethane Mice Female Gavage Liver Positive ADENOMA 4/49 8/46 24/48 OR CARCINOMA 1/49 5/46 6/48 COMBINED 5/49 13/46 30/48 Neoplastic Lesions
Yes TR-237 630-20-6 1,1,1,2-Tetrachloroethane Mice Male Gavage Liver Positive ADENOMA 6/48 14/46 21/50 Neoplastic Lesions
Yes TR-239 108-60-1 bis(2-Chloro-1-methylethyl) ether Mice Male Gavage Liver Positive CARCINOMA 5/50 13/50 17/50 Neoplastic Lesions
Yes TR-243 79-01-6 Trichloroethylene Mice Female Gavage Liver Positive ADENOMA 2/48 8/49; CARCINOMA 2/48 13/49 Neoplastic Lesions
Yes TR-243 79-01-6 Trichloroethylene Mice Male Gavage Liver Positive CARCINOMA 8/48 30/50 Neoplastic Lesions
Yes TR-244 67774-32-7 Polybrominated biphenyl mixture (Firemaster FF-1) Mice Female Gavage Liver Positive CARCINOMA 0/13 0/19 2/15 2/11 3/17 7/8 Neoplastic Lesions
Yes TR-244 67774-32-7 Polybrominated biphenyl mixture (Firemaster FF-1) Mice Male Gavage Liver Positive CARCINOMA 12/25 8/27 8/24 12/25 15/23 21/22 Neoplastic Lesions
Yes TR-244 67774-32-7 Polybrominated biphenyl mixture (Firemaster FF-1) Rats Female Gavage Liver Positive NEOPLASTIC NODULE 0/20 2/21 0/21 2/11 5/19 8/20; CARCINOMA 0/20 0/21 0/21 0/11 3/19 7/20; CHOLANGIOCARCINOMA 0/20 0/21 0/21 0/11 0/19 7/20 Neoplastic Lesions
Yes TR-244 67774-32-7 Polybrominated biphenyl mixture (Firemaster FF-1) Rats Male Gavage Liver Positive NEOPLASTIC NODULE 0/33 0/39 1/40 4/31 4/33 1/31; CARCINOMA 0/33 2/39 0/40 1/31 7/33 7/31; CHOLANGIOCARCINOMA 0/33 0/39 0/40 0/31 0/33 2/31 Neoplastic Lesions
Yes TR-248 13552-44-8 4,4'-Methylenedianiline dihydrochloride Mice Female Dosed-Water Liver Positive ADENOMA 3/50 9/50 12/50 Neoplastic Lesions
Yes TR-248 13552-44-8 4,4'-Methylenedianiline dihydrochloride Mice Male Dosed-Water Liver Positive CARCINOMA 10/49 33/50 29/50 Neoplastic Lesions
Yes TR-248 13552-44-8 4,4'-Methylenedianiline dihydrochloride Rats Male Dosed-Water Liver Positive NEOPLASTIC NODULE 1/50 12/50 25/50 Neoplastic Lesions
Yes TR-250 140-11-4 Benzyl acetate Mice Female Gavage Liver Some Evidence ADENOMA 0/50 0/50 6/50 Neoplastic Lesions
Yes TR-250 140-11-4 Benzyl acetate Mice Male Gavage Liver Some Evidence ADENOMA 0/50 5/49 13/50 Neoplastic Lesions
Yes TR-251 26471-62-5 2,4- & 2,6-Toluene diisocyanate Mice Female Gavage Liver Positive ADENOMA 2/50 3/50 12/50 Neoplastic Lesions
Yes TR-251 26471-62-5 2,4- & 2,6-Toluene diisocyanate Rats Female Gavage Liver Positive NEOPLASTIC NODULE 3/50 8/50 8/48 Neoplastic Lesions
Yes TR-263 78-87-5 1,2-Dichloropropane (propylene dichloride) Mice Female Gavage Liver Some Evidence ADENOMA 1/50 5/50 5/50 Neoplastic Lesions
Yes TR-263 78-87-5 1,2-Dichloropropane (propylene dichloride) Mice Male Gavage Liver Some Evidence ADENOMA 7/50 10/50 17/50 Neoplastic Lesions
Yes TR-266 150-68-5 Monuron Rats Male Dosed-Feed Liver Clear Evidence NEOPLASTIC NODULE 1/50 6/49 7/50 OR CARCINOMA 0/50 1/49 3/50 COMBINED 1/50 6/49 9/50 Neoplastic Lesions
Yes TR-269 542-75-6 1,3-Dichloropropene (Telone II) Rats Male Gavage Liver Clear Evidence NEOPLASTIC NODULE 1/52 6/52 7/52 Neoplastic Lesions
Yes TR-271 2784-94-3 HC blue 1 Mice Female Dosed-Feed Liver Clear Evidence CARCINOMA 1/50 24/48 47/49 Neoplastic Lesions
Yes TR-271 2784-94-3 HC blue 1 Mice Male Dosed-Feed Liver Clear Evidence CARCINOMA 11/50 20/50 30/50 Neoplastic Lesions
Yes TR-274 78-42-2 tris(2-Ethylhexyl)phosphate Mice Female Gavage Liver Some Evidence CARCINOMA 0/48 4/50 7/50 Neoplastic Lesions
Yes TR-190 156-10-5 p-Nitrosodiphenylamine Mice Male Dosed-Feed Liver Positive (CARCINOMA) Neoplastic Lesions
Yes TR-190 156-10-5 p-Nitrosodiphenylamine Rats Male Dosed-Feed Liver Positive (NEOPLASTIC NODULE OR CARCINOMA) Neoplastic Lesions
Yes TR-194 7446-34-6 Selenium sulfide Mice Female Gavage Liver Positive (ADENOMA, CARCINOMA) Neoplastic Lesions
Yes TR-194 7446-34-6 Selenium sulfide Rats Female Gavage Liver Positive (NEOPLASTIC NODULE, CARCINOMA) Neoplastic Lesions
Yes TR-194 7446-34-6 Selenium sulfide Rats Male Gavage Liver Positive (NEOPLASTIC NODULE, CARCINOMA) Neoplastic Lesions
Yes TR-196 87-29-6 Cinnamyl anthranilate Mice Female Dosed-Feed Liver Positive (ADENOMA, CARCINOMA) Neoplastic Lesions
Yes TR-196 87-29-6 Cinnamyl anthranilate Mice Male Dosed-Feed Liver Positive (ADENOMA, CARCINOMA) Neoplastic Lesions
Yes TR-198 57653-85-7 1,2,3,6,7,8-Hexachlorodibenzo-p-dioxin Mice Female Gavage Liver Positive (ADENOMA, CARCINOMA) Neoplastic Lesions
Yes TR-198 57653-85-7 1,2,3,6,7,8-Hexachlorodibenzo-p-dioxin Mice Male Gavage Liver Positive (ADENOMA, CARCINOMA) Neoplastic Lesions
Yes TR-198 57653-85-7 1,2,3,6,7,8-Hexachlorodibenzo-p-dioxin Rats Female Gavage Liver Positive (NEOPLASTIC NODULE, CARCINOMA) Neoplastic Lesions
Yes TR-288 106-99-0 1,3-Butadiene Mice Female Inhalation Liver Clear Evidence ADENOMA 0/50 1/47 4/49 OR CARCINOMA 0/50 1/47 1/49 COMBINED 0/50 2/47 5/49 Neoplastic Lesions
Yes TR-304 115-28-6 Chlorendic acid Mice Male Dosed-Feed Liver Clear Evidence ADENOMA 5/50 9/49 10/50; CARCINOMA 9/50 17/49 20/50 Neoplastic Lesions
Yes TR-304 115-28-6 Chlorendic acid Rats Female Dosed-Feed Liver Clear Evidence NEOPLASTIC NODULE 1/50 3/49 11/50; CARCINOMA 0/50 3/49 5/50 Neoplastic Lesions
Yes TR-304 115-28-6 Chlorendic acid Rats Male Dosed-Feed Liver Clear Evidence NEOPLASTIC NODULE 2/50 21/50 23/50 Neoplastic Lesions
Yes TR-306 75-09-2 Methylene chloride Mice Female Inhalation Liver Clear Evidence ADENOMA 2/50 6/48 22/48 OR CARCINOMA 1/50 11/48 32/48 COMBINED 3/50 16/48 40/48 Neoplastic Lesions
Yes TR-306 75-09-2 Methylene chloride Mice Male Inhalation Liver Clear Evidence ADENOMA 10/50 14/49 14/49 OR CARCINOMA 13/50 15/49 26/49 COMBINED 22/50 24/49 33/49 Neoplastic Lesions
Yes TR-308 108171-26-2 Chlorinated paraffins: C12, 60% chlorine Mice Female Gavage Liver Clear Evidence ADENOMA 0/50 18/50 22/50 OR CARCINOMA 3/50 4/50 9/50 COMBINED 3/50 22/50 28/50 Neoplastic Lesions
Yes TR-308 108171-26-2 Chlorinated paraffins: C12, 60% chlorine Mice Male Gavage Liver Clear Evidence ADENOMA 11/50 20/50 29/50 OR CARCINOMA 11/50 15/50 17/50 COMBINED 2/50 34/50 38/50 Neoplastic Lesions
Yes TR-308 108171-26-2 Chlorinated paraffins: C12, 60% chlorine Rats Female Gavage Liver Clear Evidence NEOPLASTIC NODULE 0/50 4/50 7/50; CARCINOMA 0/50 1/50 1/50 Neoplastic Lesions
Yes TR-328 598-55-0 Methyl carbamate Rats Female Gavage Liver Clear Evidence NEOPLASTIC NODULE 0/50 0/50 5/49; CARCINOMA 0/50 0/50 1/50 Neoplastic Lesions
Yes TR-328 598-55-0 Methyl carbamate Rats Male Gavage Liver Clear Evidence NEOPLASTIC NODULE 3/50 0/50 3/49; CARCINOMA 1/50 0/50 4/49 Neoplastic Lesions
Yes TR-308 108171-26-2 Chlorinated paraffins: C12, 60% chlorine Rats Male Gavage Liver Clear Evidence NEOPLASTIC NODULE 0/50 10/50 16/48; CARCINOMA 0/50 3/50 2/48 Neoplastic Lesions
Yes TR-309 1163-19-5 Decabromodiphenyl oxide Rats Female Dosed-Feed Liver Some Evidence NEOPLASTIC NODULE 1/50 3/49 9/50 Neoplastic Lesions
Yes TR-309 1163-19-5 Decabromodiphenyl oxide Rats Male Dosed-Feed Liver Some Evidence NEOPLASTIC NODULE 1/50 7/50 15/49 Neoplastic Lesions
Yes TR-311 127-18-4 Tetrachloroethylene Mice Female Inhalation Liver Clear Evidence CARCINOMA 1/48 13/50 36/50 Neoplastic Lesions
Yes TR-311 127-18-4 Tetrachloroethylene Mice Male Inhalation Liver Clear Evidence ADENOMA 11/49 8/49 18/50; CARCINOMA 7/49 25/49 26/50 Neoplastic Lesions
Yes TR-313 2385-85-5 Mirex Rats Female Dosed-Feed Liver Clear Evidence NEOPLASTIC NODULE 2/52 23/52 30/52 Neoplastic Lesions
Yes TR-313 2385-85-5 Mirex Rats Male Dosed-Feed Liver Clear Evidence NEOPLASTIC NODULE 3/52 5/52 5/52 14/52 15/52 26/52 Neoplastic Lesions
Yes TR-319 106-46-7 1,4-Dichlorobenzene (p-dichlorobenzene) Mice Female Gavage Liver Clear Evidence ADENOMA 10/50 6/48 21/50; CARCINOMA 5/50 5/48 19/50 Neoplastic Lesions
Yes TR-319 106-46-7 1,4-Dichlorobenzene (p-dichlorobenzene) Mice Male Gavage Liver Clear Evidence ADENOMA 5/50 13/49 16/50; CARCINOMA 14/50 11/49 32/50 Neoplastic Lesions
Yes TR-321 75-27-4 Bromodichloromethane Mice Female Gavage Liver Clear Evidence ADENOMA 1/50 13/48 23/50; CARCINOMA 2/50 5/48 10/50 Neoplastic Lesions
Yes TR-282 124-48-1 Chlorodibromomethane Mice Female Gavage Liver Some Evidence ADENOMA 2/50 4/49 11/50 OR CARCINOMA 4/50 6/49 8/50 COMBINED 6/50 10/49 19/50 Neoplastic Lesions
Yes TR-285 569-61-9 C.I. Basic red 9 monohydrochloride Mice Female Dosed-Feed Liver Clear Evidence CARCINOMA 3/49 19/50 37/49 Neoplastic Lesions
Yes TR-285 569-61-9 C.I. Basic red 9 monohydrochloride Mice Male Dosed-Feed Liver Clear Evidence CARCINOMA 10/50 20/50 27/50 Neoplastic Lesions
Yes TR-285 569-61-9 C.I. Basic red 9 monohydrochloride Rats Male Dosed-Feed Liver Clear Evidence CARCINOMA 0/50 2/50 8/50 Neoplastic Lesions
Yes TR-372 20325-40-0 3,3'-Dimethoxybenzidine dihydrochloride Rats Male Dosed-Water Liver Clear Evidence NEOPLASTIC NODULE 0/60 3/45 7/74 6/60; NEOPLASTIC NODULE OR CARCINOMA 1/60 1/45 0/74 2/60 COMBINED 1/60 4/45 7/74 8/60 Neoplastic Lesions
Yes TR-374 556-52-5 Glycidol Mice Male Gavage Liver Clear Evidence ADENOMA 18/50 16/50 30/50 OR CARCINOMA 10/50 17/50 8/50 COMBINED 24/50 31/50 35/50 Neoplastic Lesions
Yes TR-382 98-01-1 Furfural Mice Female Gavage Liver Some Evidence ADENOMA 1/50 3/50 5/50 8/50 Neoplastic Lesions
Yes TR-382 98-01-1 Furfural Mice Male Gavage Liver Clear Evidence ADENOMA 9/50 13/50 11/49 19/50; CARCINOMA 7/50 12/50 6/49 21/50 Neoplastic Lesions
Yes TR-382 98-01-1 Furfural Rats Male Gavage Liver Some Evidence CHOLANGIOCARCINOMA 0/50 0/50 2/50 Neoplastic Lesions
Yes TR-383 81-49-2 1-Amino-2,4-dibromoanthraquinone Mice Female Dosed-Feed Liver Clear Evidence ADENOMA 6/50 45/50 49/50; CARCINOMA 0/50 23/50 27/50 Neoplastic Lesions
Yes TR-383 81-49-2 1-Amino-2,4-dibromoanthraquinone Mice Male Dosed-Feed Liver Clear Evidence ADENOMA 10/50 38/51 39/50; CARCINOMA 9/50 18/51 21/50 Neoplastic Lesions
Yes TR-383 81-49-2 1-Amino-2,4-dibromoanthraquinone Rats Female Dosed-Feed Liver Clear Evidence ADENOMA 0/50 28/40 47/60 29/48; CARCINOMA 0/50 12/40 57/60 45/48; HEPATOCHOLANGIOCARCINOMA 0/50 0/40 11/60 13/48 Neoplastic Lesions
Yes TR-383 81-49-2 1-Amino-2,4-dibromoanthraquinone Rats Male Dosed-Feed Liver Clear Evidence ADENOMA 1/50 20/40 40/59 34/50; CARCINOMA 1/50 12/40 55/59 46/50; HEPATOCHOLANGIOCARCINOMA 0/50 0/40 6/59 2/50 Neoplastic Lesions
Yes TR-384 96-18-4 1,2,3-Trichloropropane Mice Female Gavage Liver Clear Evidence ADENOMA 6/50 9/50 8/51 31/55 OR CARCINOMA 1/50 3/50 0/51 2/55 COMBINED 7/50 11/50 8/51 31/55 Neoplastic Lesions
Yes TR-349 87-86-5 Pentachlorophenol, Dowicide EC-7 Mice Female Dosed-Feed Liver Clear Evidence ADENOMA 1/34 3/50 6/49 30/48 OR CARCINOMA 0/34 1/50 0/49 1/48 COMBINED 1/34 4/50 6/49 31/48 Neoplastic Lesions
Yes TR-349 87-86-5 Pentachlorophenol, Dowicide EC-7 Mice Male Dosed-Feed Liver Clear Evidence ADENOMA 5/35 13/48 17/48 32/49 OR CARCINOMA 1/35 7/48 7/48 9/49 COMBINED 6/35 19/48 21/48 34/49 Neoplastic Lesions
Yes TR-349 87-86-5 Pentachlorophenol, technical Mice Female Dosed-Feed Liver Some Evidence ADENOMA 3/33 8/49 8/50 OR CARCINOMA 0/33 1/49 1/50 COMBINED 3/33 9/49 9/50 Neoplastic Lesions
Yes TR-349 87-86-5 Pentachlorophenol, technical Mice Male Dosed-Feed Liver Clear Evidence ADENOMA 5/32 20/47 33/48 OR CARCINOMA 2/32 10/47 12/48 COMBINED 7/32 26/47 37/48 Neoplastic Lesions
Yes TR-351 20265-96-7 p-Chloroaniline hydrochloride Mice Male Gavage Liver Some Evidence ADENOMA 9/50 15/49 10/50 44/50 OR CARCINOMA 3/50 7/49 11/50 17/50 COMBINED 11/50 21/49 20/50 21/50 Neoplastic Lesions
Yes TR-352 924-42-5 N-Methylolacrylamide Mice Female Gavage Liver Clear Evidence ADENOMA 3/50 4/50 17/49 Neoplastic Lesions
Yes TR-352 924-42-5 N-Methylolacrylamide Mice Male Gavage Liver Clear Evidence ADENOMA 8/50 4/50 19/50 OR CARCINOMA 6/50 13/50 12/50 COMBINED 12/50 17/50 26/50 Neoplastic Lesions
Yes TR-366 123-31-9 Hydroquinone Mice Female Gavage Liver Some Evidence Adenoma 2/55 15/55 12/55; adenoma or carcinoma (combined) 3/55 16/55 13/55 Neoplastic Lesions
Yes TR-367 50-33-9 Phenylbutazone Mice Male Gavage Liver Some Evidence ADENOMA 8/50 12/50 24/50 OR CARCINOMA 8/50 4/50 11/50 COMBINED 16/50 14/50 31/50 Neoplastic Lesions
Yes TR-370 271-89-6 Benzofuran Mice Female Gavage Liver Clear Evidence ADENOMA 1/50 22/48 21/47; HEPATOBLASTOMA 0/50 1/48 2/47; ADENOMA, HEPATOBLASTOMA, OR CARCINOMA 3/50 3/48 1/47 COMBINED 4/50 25/48 22/47 Neoplastic Lesions
Yes TR-370 271-89-6 Benzofuran Mice Male Gavage Liver Clear Evidence ADENOMA 4/49 24/39 34/48; HEPATOBLASTOMA 0/49 3/39 18/48; ADENOMA, HEPATOBLASTOMA, OR CARCINOMA 9/49 8/39 9/48 COMBINED 12/49 31/39 40/48 Neoplastic Lesions
Yes TR-372 20325-40-0 3,3'-Dimethoxybenzidine dihydrochloride Rats Female Dosed-Water Liver Clear Evidence NEOPLASTIC NODULE 0/60 1/44 0/75 2/60 OR CARCINOMA 0/60 0/44 0/75 1/60 COMBINED 0/60 1/44 0/75 3/60 Neoplastic Lesions
Yes TR-390 612-82-8 3,3'-Dimethylbenzidine dihydrochloride Rats Female Dosed-Water Liver Clear Evidence NEOPLASTIC NODULE 0/60 0/45 7/74 3/60 OR CARCINOMA 0/60 0/45 1/74 1/60 COMBINED 0/60 0/45 7/74 4/60 Neoplastic Lesions
Yes TR-390 612-82-8 3,3'-Dimethylbenzidine dihydrochloride Rats Male Dosed-Water Liver Clear Evidence NEOPLASTIC NODULE 0/60 0/45 29/75 26/60 OR CARCINOMA 0/60 0/45 12/75 12/60 COMBINED 0/60 0/45 35/75 33/60 Neoplastic Lesions
Yes TR-395 57-66-9 Probenecid Mice Female Gavage Liver Some Evidence ADENOMA 3/48 2/49 14/49, CARCINOMA 2/48 2/49 3/49, COMBINED 5/48 3/49 16/49 Neoplastic Lesions
Yes TR-397 2429-74-5 C.I. Direct blue 15 Rats Female Dosed-Water Liver Clear Evidence NEOPLASTIC NODULE 0/50 0/35 2/65 4/50, CARCINOMA 0/50 0/35 0/65 1/50, COMBINED 0/50 0/35 2/65 5/50 Neoplastic Lesions
Yes TR-397 2429-74-5 C.I. Direct blue 15 Rats Male Dosed-Water Liver Clear Evidence NEOPLASTIC NODULE 0/50 6/35 8/65 7/50, CARCINOMA 0/50 0/35 1/65 4/50, COMBINED 0/50 6/35 9/65 11/50 Neoplastic Lesions
Yes TR-398 67774-32-7 Polybrominated biphenyl mixture (Firemaster FF-1) Mice Female Dosed-Feed Liver Clear Evidence ADENOMA 4/50 39/50 46/48; CARCINOMA 1/50 22/50 35/48 Neoplastic Lesions
Yes TR-398 67774-32-7 Polybrominated biphenyl mixture (Firemaster FF-1) Mice Male Dosed-Feed Liver Clear Evidence ADENOMA 9/50 48/49 42/50; CARCINOMA 8/50 30/49 36/50 Neoplastic Lesions
Yes TR-398 67774-32-7 Polybrominated biphenyl mixture (Firemaster FF-1) Rats Female Dosed-Feed Liver Clear Evidence ADENOMA 0/50 10/50 38/50 OR CARCINOMA 0/50 2/50 4/50 COMBINED 0/50 12/50 39/50 Neoplastic Lesions
Yes TR-398 67774-32-7 Polybrominated biphenyl mixture (Firemaster FF-1) Rats Male Dosed-Feed Liver Clear Evidence ADENOMA 1/50 10/49 38/50 OR CARCINOMA 0/50 2/49 19/50 COMBINED 1/50 12/49 41/50 Neoplastic Lesions
Yes TR-400 96-13-9 2,3-Dibromo-1-propanol Mice Male Topical Application Liver Clear Evidence ADENOMA 1/50 2/50 9/50 OR CARCINOMA 0/50 0/50 3/50 COMBINED 1/50 2/50 11/50 Neoplastic Lesions
Yes TR-400 96-13-9 2,3-Dibromo-1-propanol Rats Female Topical Application Liver Clear Evidence NEOPLASTIC NODULES 0/50 10/50 11/50 OR CARCINOMA 0/50 2/50 6/50 COMBINED 0/50 11/50 14/50 Neoplastic Lesions
Yes TR-400 96-13-9 2,3-Dibromo-1-propanol Rats Male Topical Application Liver Clear Evidence NEOPLASTIC NODULES 0/49 3/50 2/50 OR CARCINOMA 0/49 1/50 3/50 COMBINED 0/49 4/50 5/50 Neoplastic Lesions
Yes TR-402 110-00-9 Furan Mice Female Gavage Liver Clear Evidence ADENOMA 5/50 31/50 48/50, CARCINOMA 2/50 7/50 27/50, COMBINED 7/50 34/50 50/50 Neoplastic Lesions
Yes TR-402 110-00-9 Furan Mice Male Gavage Liver Clear Evidence ADENOMA 20/50 33/50 42/50, CARCINOMA 7/50 32/50 34/50, COMBINED 26/50 44/50 50/50 Neoplastic Lesions
Yes TR-402 110-00-9 Furan Rats Female Gavage Liver Clear Evidence ADENOMA 0/50 2/50 4/50 7/50, CARCINOMA 0/50 0/50 0/50 1/50, COMBINED 0/50 2/50 4/50 8/50; CHOLANGIOCARCINOMA 0/50 49/50 50/50 48/50 Neoplastic Lesions
Yes TR-402 110-00-9 Furan Rats Male Gavage Liver Clear Evidence ADENOMA 1/50 4/50 18/50 27/50, CARCINOMA 0/50 1/50 6/50 18/50, COMBINED 1/50 5/50 22/50 35/50; CHOLANGIOCARCINOMA 0/50 43/50 48/50 49/50 Neoplastic Lesions
Yes TR-404 57-41-0 5,5-Diphenylhydantoin (phenytoin) Mice Female Dosed-Feed Liver Clear Evidence ADENOMA 5/48 13/49 22/50, HEPATOBLASTOMA OR CARCINOMA 0/48 1/49 12/50, COMBINED 5/48 14/49 30/50 Neoplastic Lesions
Yes TR-405 6459-94-5 C.I. Acid red 114 Rats Female Dosed-Water Liver Clear Evidence NEOPLASTIC NODULE 0/50 0/35 15/64 6/50, CARCINOMA 0/50 0/35 6/64 3/50, COMBINED 0/50 0/35 19/64 8/50 Neoplastic Lesions
Yes TR-405 6459-94-5 C.I. Acid red 114 Rats Male Dosed-Water Liver Clear Evidence NEOPLASTIC NODULE 2/50 1/35 10/65 15/50, CARCINOMA 0/50 1/35 6/65 7/50, COMBINED 2/50 2/35 15/65 20/50 Neoplastic Lesions
Yes TR-407 2425-85-6 C.I. Pigment red 3 Rats Female Dosed-Feed Liver Some Evidence ADENOMA 0/50 0/50 1/50 10/50 Neoplastic Lesions
Yes TR-416 91-23-6 o-Nitroanisole Mice Female Dosed-Feed Liver Some Evidence ADENOMA 14/50 2/50 36/50 18/50 Neoplastic Lesions
Yes TR-416 91-23-6 o-Nitroanisole Mice Male Dosed-Feed Liver Clear Evidence ADENOMA 14/50 26/50 41/50 29/50; CARCINOMA 7/50 12/50 11/50 7/50; HEPATOBLASTOMA 0/50 3/50 17/50 9/50 Neoplastic Lesions
Yes TR-384 96-18-4 1,2,3-Trichloropropane Mice Male Gavage Liver Clear Evidence ADENOMA 11/52 18/51 21/54 29/56; CARCINOMA 13/52 24/51 24/54 31/56 Neoplastic Lesions
Yes TR-388 96-45-7 Ethylene thiourea (ETU) Mice Female Dosed-Feed Liver Clear Evidence ADENOMA 9/50 2/50 33/50; CARCINOMA 2/50 29/50 47/50 Neoplastic Lesions
Yes TR-388 96-45-7 Ethylene thiourea (ETU) Mice Male Dosed-Feed Liver Clear Evidence ADENOMA 11/49 16/50 9/50; CARCINOMA 13/49 19/50 45/50 Neoplastic Lesions
Yes TR-466 100-41-4 Ethylbenzene Mice Female Inhalation Liver Some Evidence ADENOMA 6/50 9/50 12/50 16/50 OR CARCINOMA 7/50 4/50 3/50 12/50 COMBINED 13/50 12/50 15/50 25/50 Neoplastic Lesions
Yes TR-467 126-99-8 Chloroprene Mice Female Inhalation Liver Clear Evidence ADENOMA 17/50 19/49 11/50 16/50 OR CARCINOMA 4/50 11/49 14/50 19/50 COMBINED 20/50 26/49 20/50 30/50 Neoplastic Lesions
Yes TR-457 599-79-1 Salicylazosulfapyridine Mice Female Gavage Liver Clear Evidence ADENOMA 12/50 28/50 25/50 28/49 OR CARCINOMA 2/50 10/50 10/50 9/49 COMBINED 14/50 32/50 28/50 29/49 Neoplastic Lesions
Yes TR-457 599-79-1 Salicylazosulfapyridine Mice Female Gavage Liver Clear Evidence ADENOMA 12/50 28/50 25/50 28/49 OR CARCINOMA 2/50 10/50 10/50 9/49 COMBINED 14/50 32/50 28/50 29/49 Neoplastic Lesions
Yes TR-457 599-79-1 Salicylazosulfapyridine Mice Male Gavage Liver Clear Evidence ADENOMA 13/50 32/50 28/50 42/50 OR CARCINOMA 13/50 15/50 23/50 8/50 COMBINED 24/50 38/50 38/50 44/50 Neoplastic Lesions
Yes TR-457 599-79-1 Salicylazosulfapyridine Mice Male Gavage Liver Clear Evidence ADENOMA 13/50 32/50 28/50 42/50 OR CARCINOMA 13/50 15/50 23/50 8/50 COMBINED 24/50 38/50 38/50 44/50 Neoplastic Lesions
Yes TR-461 75-52-5 Nitromethane Mice Female Inhalation Liver Clear Evidence ADENOMA 14/50 25/50 17/50 35/50 OR CARCINOMA 10/50 14/50 8/50 12/50 COMBINED 19/50 34/50 22/50 40/50 Neoplastic Lesions
Yes TR-463 8003-22-3 D & C yellow no. 11 Rats Female Dosed-Feed Liver Some Evidence ADENOMA 0/50 2/51 5/50 4/51 OR CARCINOMA 0/50 0/51 0/50 1/51 COMBINED 0/50 2/51 5/50 5/51 Neoplastic Lesions
Yes TR-463 8003-22-3 D & C yellow no. 11 Rats Male Dosed-Feed Liver Some Evidence ADENOMA 1/50 2/51 1/51 7/54 Neoplastic Lesions
Yes TR-420 396-01-0 Triamterene Mice Female Dosed-Feed Liver Some Evidence (FIRST STUDY) ADENOMA 10/50 22/50 23/50 36/60 OR CARCINOMA 4/50 4/50 3/50 8/60 COMBINED 13/50 26/50 25/50 37/60; (SECOND STUDY) ADENOMA 7/50 28/51 OR CARCINOMA 5/50 11/51 COMBINED 10/50 31/51 Neoplastic Lesions
Yes TR-420 396-01-0 Triamterene Mice Male Dosed-Feed Liver Some Evidence (FIRST STUDY) ADENOMA 17/50 22/50 19/50 20/60 OR CARCINOMA 5/50 7/50 3/50 13/60 COMBINED 20/50 26/50 19/50 29/60; (SECOND STUDY) ADENOMA 21/50 36/50 OR CARCINOMA 9/50 11/50 COMBINED 25/50 38/50 Neoplastic Lesions
Yes TR-422 91-64-5 Coumarin Mice Female Gavage Liver Clear Evidence ADENOMA 8/50 26/49 29/51 12/50 Neoplastic Lesions
Yes TR-423 119-84-6 3,4-Dihydrocoumarin Mice Female Gavage Liver Some Evidence ADENOMA 10/51 20/50 22/50 20/52 OR CARCINOMA 3/51 2/50 4/50 6/52 COMBINED 13/51 21/50 25/50 24/52 Neoplastic Lesions
Yes TR-430 28407-37-6 C.I. Direct blue 218 Mice Female Dosed-Feed Liver Clear Evidence ADENOMA 7/49 12/50 17/49 41/49; CARCINOMA 5/49 5/50 6/49 12/49 Neoplastic Lesions
Yes TR-430 28407-37-6 C.I. Direct blue 218 Mice Male Dosed-Feed Liver Clear Evidence ADENOMA 16/50 19/50 17/50 40/50; CARCINOMA 7/50 3/50 8/50 17/50 Neoplastic Lesions
Yes TR-434 106-99-0 1,3-Butadiene Mice Female Inhalation Liver Clear Evidence ADENOMA OR CARCINOMA 15/49 14/49 15/50 19/50 16/50 2/80 Neoplastic Lesions
Yes TR-434 106-99-0 1,3-Butadiene Mice Male Inhalation Liver Clear Evidence ADENOMA OR CARCINOMA 21/50 23/50 30/50 25/48 33/48 5/72, STOP STUDY 27/49 19/49 19/50 11/50 Neoplastic Lesions
Yes TR-439 298-59-9 Methylphenidate hydrochloride Mice Female Dosed-Feed Liver Some Evidence HEPATOCELLULAR ADENOMA 6/49 10/48 10/49 28/50 CARCINOMA 5/49 3/48 2/49 6/50 COMBINED 9/49 11/48 11/49 30/50 Neoplastic Lesions
Yes TR-439 298-59-9 Methylphenidate hydrochloride Mice Male Dosed-Feed Liver Some Evidence HEPATOCELLULAR ADENOMA 18/50 18/50 16/50 29/50 CARCINOMA 10/50 9/50 17/50 11/50 COMBINED 24/50 23/50 26/50 34/50; HEPATOBLASTOMA 0/50 1/50 1/50 5/50 Neoplastic Lesions
Yes TR-443 604-75-1 Oxazepam Mice Female Dosed-Feed Liver Clear Evidence (SWISS-WEBSTER) ADENOMA 0/60 22/59 47/59; CARCINOMA 1/60 1/59 11/59; (B6C3F1) ADENOMA 25/50 35/50 35/50 36/50; CARCINOMA 9/50 5/50 49/50 44/50; HEPATOBLASTOMA 0/50 1/50 8/50 8/50 Neoplastic Lesions
Yes TR-443 604-75-1 Oxazepam Mice Male Dosed-Feed Liver Clear Evidence (SWISS-WEBSTER) ADENOMA 1/60 35/60 50/60; CARCINOMA 0/60 5/60 19/60; (B6C3F1) ADENOMA 17/49 18/50 34/50 32/50; CARCINOMA 9/49 5/50 45/50 50/50; HEPATOBLASTOMA 0/49 2/50 21/50 13/50 Neoplastic Lesions
Yes TR-450 116-14-3 Tetrafluoroethylene Mice Female Inhalation Liver Clear Evidence ADENOMA 15/48 17/48 20/47 15/47 OR CARCINOMA 4/48 28/48 22/47 20/47 COMBINED 17/48 33/48 29/47 28/47 Neoplastic Lesions
Yes TR-450 116-14-3 Tetrafluoroethylene Mice Male Inhalation Liver Clear Evidence ADENOMA 17/48 17/48 12/48 20/48 OR CARCINOMA 11/48 20/48 33/48 26/48 COMBINED 26/48 34/48 39/48 35/48 Neoplastic Lesions
Yes TR-450 116-14-3 Tetrafluoroethylene Rats Female Inhalation Liver Clear Evidence ADENOMA 0/50 4/50 5/50 6/50 OR CARCINOMA 0/50 4/50 9/50 2/50 COMBINED 0/50 7/50 12/50 8/50 Neoplastic Lesions
Yes TR-450 116-14-3 Tetrafluoroethylene Rats Male Inhalation Liver Clear Evidence ADENOMA 3/50 6/50 8/50 5/50 OR CARCINOMA 1/50 1/50 10/50 3/50 COMBINED 4/50 7/50 15/50 8/50 Neoplastic Lesions
Yes TR-478 111-42-2 Diethanolamine Mice Female Topical Application Liver Clear Evidence ADENOMA 32/50 50/50 48/50 48/50 OR CARCINOMA 5/50 19/50 38/50 42/50 Neoplastic Lesions
Yes TR-478 111-42-2 Diethanolamine Mice Male Topical Application Liver Clear Evidence ADENOMA 31/50 42/50 49/50 45/50, CARCINOMA 12/50 17/50 33/50 34/50 OR HEPATOBLASTOMA 0/50 2/50 8/50 5/50 Neoplastic Lesions
Yes TR-479 68603-42-9 Coconut oil acid diethanolamine condensate Mice Female Topical Application Liver Clear Evidence adenoma 32/50, 44/50, 43/50; hepatocellular carcinoma 3/50, 21/50, 32/50; hepatocellular adenoma, carcinoma, or hepatoblastoma 33/50, 46/50, 48/50 Neoplastic Lesions
Yes TR-479 68603-42-9 Coconut oil acid diethanolamine condensate Mice Male Topical Application Liver Clear Evidence adenoma 22/50, 35/50, 45/50; hepatoblastoma 1/50, 1/50, 10/50; hepatocellular adenoma, carcinoma, or hepatoblastoma 29/50, 39/50, 49/50 Neoplastic Lesions
Yes TR-480 120-40-1 Lauric acid diethanolamine condensate Mice Female Topical Application Liver Some Evidence ADENOMA 23/50 32/49 29/50 ADENOMA OR CARCINOMA COMBINED 28/50 40/49 36/50 Neoplastic Lesions
Yes TR-485 434-07-1 Oxymetholone Rats Female Gavage Liver Clear Evidence ADENOMA 1/50 1/50 1/50 8/49 COMBINED 1/50 1/50 1/50 10/49 Neoplastic Lesions
Yes TR-491 93-15-2 Methyleugenol Mice Female Gavage Liver Clear Evidence ADENOMA 20/50 48/50 46/49 41/50 OR CARCINOMA 7/50 37/50 47/49 47/50 COMBINED 25/50 50/50 49/49 49/50; HEPATOBLASTOMA 0/50 6/50 11/49 15/50; HEPATOCHOLANGIOCARCINOMA 0/50 0/50 0/50 2/50 Neoplastic Lesions
Yes TR-491 93-15-2 Methyleugenol Mice Male Gavage Liver Clear Evidence ADENOMA 26/49 43/50 38/50 39/50 CARCINOMA 10/49 20/50 19/50 9/50 COMBINED 31/49 47/50 46/50 40/50; HEPATOBLASTOMA 0/49 0/50 1/50 3/50 Neoplastic Lesions
Yes TR-491 93-15-2 Methyleugenol Rats Female Gavage Liver Clear Evidence ADENOMA 1/50 8/50 11/49 33/49 43/50 OR CARCINOMA 0/50 0/50 4/49 8/49 22/50 COMBINED 1/50 8/50 14/49 34/49 43/50; HEPATOCHOLANGIOMA 0/50 0/50 0/49 0/49 8/50 OR HEPATOCHOLANGIOCARCINOMA 0/50 0/50 0/49 3/49 9/50 COMBINED 0/50 0/50 0/49 3/49 17/50 Neoplastic Lesions
Yes TR-491 93-15-2 Methyleugenol Rats Male Gavage Liver Clear Evidence ADENOMA 5/50 12/50 23/50 38/50 32/50 OR CARCINOMA 2/50 3/50 14/50 25/50 36/50 COMBINED 7/50 14/50 28/50 43/50 45/50; HEPATOCHOLANGIOMA 0/50 0/50 0/50 1/50 6/50 OR HEPATOCHOLANGIOCARCINOMA 0/50 0/50 1/50 1/50 7/50 COMBINED 0/50 0/50 1/50 2/50 13/50 Neoplastic Lesions
Yes TR-494 84-65-1 Anthraquinone Mice Female Dosed-Feed Liver Clear Evidence ADENOMA 6/49 28/50 27/50 40/49 OR CARCINOMA 2/49 3/50 8/50 8/49 COMBINED 6/49 30/50 30/50 41/49 Neoplastic Lesions
Yes TR-494 84-65-1 Anthraquinone Mice Male Dosed-Feed Liver Clear Evidence ADENOMA 21/50 32/50 38/50 41/49 OR CARCINOMA 8/50 13/50 17/50 21/49 OR HEPATOBLASTOMA 1/50 6/50 11/50 37/49 COMBINED 26/50 35/50 43/50 48/49 Neoplastic Lesions
Yes TR-494 84-65-1 Anthraquinone Rats Female Dosed-Feed Liver Clear Evidence ADENOMA 0/50 2/50 6/50 4/50 3/50 Neoplastic Lesions
Yes TR-496 116355-83-0 Fumonisin B1 Mice Female Dosed-Feed Liver Clear Evidence ADENOMA 5/47 3/48 1/48 16/47 31/45 OR CARCINOMA 0/47 0/48 0/48 10/47 9/45 COMBINED 5/47 3/48 1/48 19/47 39/45 Neoplastic Lesions
Yes TR-499 22398-80-7 Indium phosphide Mice Female Inhalation Liver Clear Evidence ADENOMA 12/50 14/50 18/50 14/50; CARCINOMA 6/50 17/50 8/50 10/50; COMBINED 18/50 28/50 24/50 23/50 Neoplastic Lesions
Yes TR-499 22398-80-7 Indium phosphide Mice Male Inhalation Liver Clear Evidence ADENOMA 17/50 24/50 23/50 32/50; CARCINOMA 11/50 22/50 23/50 16/50; COMBINED 26/50 40/50 37/50 39/50 Neoplastic Lesions
Yes TR-503 302-17-0 Chloral hydrate Mice Male Gavage Liver Some Evidence ADEMONA OR CARCINOMA 16/48 25/48 23/47 22/48 (AD LIBITUM-FED GROUPS) Neoplastic Lesions
Yes TR-503 302-17-0 Chloral hydrate Mice Male Gavage Liver Some Evidence CARCINOMA 2/48 5/58 4/48 8/48 (DIETARY-CONTROLLED GROUPS) Neoplastic Lesions
Yes TR-504 88-72-2 o-Nitrotoluene Mice Female Dosed-Feed Liver Clear Evidence ADENOMA 7/60 5/59 19/59 29/60 CARCINOMA 2/60 4/59 6/59 16/60 COMBINED 9/60 9/59 24/59 39/60 Neoplastic Lesions
Yes TR-504 88-72-2 o-Nitrotoluene Rats Male Dosed-Feed Liver Clear Evidence ADENOMA 2/60 3/60 3/60 7/60 3/60 4/60 ADENOMA OR CARCINOMA 3/60 3/60 3/60 8/60 3/60 6/60 CHOLANGIOCARCINOMA 0/60 0/60 0/60 0/60 0/60 3/60 HEPATOCHOLANGIOCARCINOMA 0/60 1/60 0/60 1/60 0/60 0/60 Neoplastic Lesions
Yes TR-508 23246-96-0 Riddelliine Mice Male Gavage Liver Clear Evidence HEMANGIOSARCOMA 2/50 1/50 0/50 2/50 31/50 Neoplastic Lesions
Yes TR-508 23246-96-0 Riddelliine Rats Female Gavage Liver Clear Evidence HEMANGIOSARCOMA 0/50 0/50 0/50 0/50 3/50 38/50; ADENOMA 1/50 0/50 0/50 0/50 1/50 7/50 Neoplastic Lesions
Yes TR-508 23246-96-0 Riddelliine Rats Male Gavage Liver Clear Evidence HEMANGIOSARCOMA 0/50 43/50; ADENOMA 0/50 4/50 Neoplastic Lesions
Yes TR-510 51-79-6 Urethane Mice Female Dosed-Water Liver Clear Evidence HEMANGIOSARCOMA 0/48 0/47 1/47 7/47 ADENOMA 5/48 10/47 19/47 18/47 ADENOMA OR CARCINOMA 5/48 11/47 20/47 19/47 Neoplastic Lesions
Yes TR-510 51-79-6 Urethane Mice Male Dosed-Water Liver Clear Evidence HEMANGIOSARCOMA 1/46 2/47 5/46 13/44 ADENOMA 7/46 13/47 17/46 17/44 ADENOMA OR CARCINOMA 12/46 18/47 24/46 23/44 Neoplastic Lesions
Yes TR-512 37319-17-8 Elmiron (sodium pentosanpolysulfate) Mice Female Gavage Liver Some Evidence HEMANGIOSARCOMA 1/50 1/49 1/50 4/49; ADENOMA 7/50 5/49 4/50 15/49; HEPATOCELLULAR ADENOMA OR CARCINOMA 10/50 8/49 9/50 18/49 Neoplastic Lesions
Yes TR-512 37319-17-8 Elmiron (sodium pentosanpolysulfate) Mice Male Gavage Liver Some Evidence HEMANGIOSARCOMA 2/50 0/50 4/50 9/50 Neoplastic Lesions
Yes TR-515 57018-52-7 Propylene glycol mono-t-butyl ether Mice Female Inhalation Liver Clear Evidence ADENOMA 14/49 8/50 10/50 37/49 CARCINOMA 4/49 8/50 7/50 10/49 COMBINED 18/49 14/50 16/50 41/49 HEPATOBLASTOMA 0/49 0/50 0/50 2/49 Neoplastic Lesions
Yes TR-515 57018-52-7 Propylene glycol mono-t-butyl ether Mice Male Inhalation Liver Clear Evidence ADENOMA 18/50 23/49 26/50 36/50 CARCINOMA 9/50 8/49 13/50 11/50 COMBINED 25/50 26/49 33/50 41/50 HEPATOBLASTOMA 0/50 0/49 1/50 5/50 Neoplastic Lesions
Yes TR-516 693-98-1 2-Methylimidazole Mice Female Dosed-Feed Liver Some Evidence ADENOMA 3/50 4/49 6/49 10/50 Neoplastic Lesions
Yes TR-516 693-98-1 2-Methylimidazole Mice Male Dosed-Feed Liver Some Evidence ADENOMA 7/50 14/50 13/50 18/50 CARCINOMA 4/50 8/50 14/50 6/50 COMBINED 10/50 22/50 22/50 22/50 Neoplastic Lesions
Yes TR-470 110-86-1 Pyridine Mice Female Dosed-Water Liver Clear Evidence ADENOMA 37/49 39/50 43/50 34/50, CARCINOMA 13/49 23/50 33/50 41/50, HEPATOBLASTOMA 1/49 2/50 9/50 16/50 COMBINED 41/49, 42/50, 45/50, 44/50 Neoplastic Lesions
Yes TR-470 110-86-1 Pyridine Mice Male Dosed-Water Liver Clear Evidence ADENOMA 29/50 40/50 34/49 39/50, CARCINOMA 15/50 35/50 41/49 40/50, HEPATOBLASTOMA 2/50 18/50 22/49 15/50; COMBINED 38/50, 47/50, 46/49, 47/50 Neoplastic Lesions
Yes TR-475 109-99-9 Tetrahydrofuran Mice Female Inhalation Liver Clear Evidence ADENOMA 12/50 17/50 18/50 31/48 OR CARCINOMA 6/50 10/50 10/50 16/48 COMBINED 17/50 24/50 26/50 41/48 Neoplastic Lesions
Yes TR-476 125-33-7 Primidone (primaclone) Mice Female Dosed-Feed Liver Clear Evidence ADENOMA 15/50 42/50 45/49 47/50, CARCINOMA 3/50 11/50 19/49 38/50 OR HEPATOBLASTOMA 1/50 4/50 4/49 4/50 COMBINED 16/50 42/50 46/49 50/50 Neoplastic Lesions
Yes TR-476 125-33-7 Primidone (primaclone) Mice Male Dosed-Feed Liver Clear Evidence ADENOMA 22/50 41/50 39/50 32/50, CARCINOMA 12/50 31/50 35/50 38/50 OR HEPATOBLASTOMA 0/50 17/50 26/50 7/50 COMBINED 31/50 49/50 49/50 46/50 Neoplastic Lesions
Yes TR-554 67-47-0 5-(Hydroxymethyl)-2-furfural Mice Female Gavage Liver Some Evidence Adenoma 14/50 26/49 26/50 6/50 Neoplastic Lesions
Yes TR-557 123-35-3 beta-Myrcene Mice Male Gavage Liver Clear Evidence Adenoma 26/50 41/50 43/50 carcinoma 14/50 20/50 28/50 adenoma or carcinoma 33/50 44/50 48/50 hepatoblastoma 4/50 6/50 11/50 adenoma, carcinoma, or hepatoblastoma 34/50 45/50 48/50 Neoplastic Lesions
Yes TR-558 14047-09-7 3,3',4,4'-Tetrachloroazobenzene Rats Female Gavage Liver Clear Evidence Cholangiocarcinoma 1/50 1/50 1/49 3/49 Neoplastic Lesions
Yes TR-558 14047-09-7 3,3',4,4'-Tetrachloroazobenzene Rats Male Gavage Liver Clear Evidence Cholangiocarcinoma 0/50 4/50 4/50 6/50 Neoplastic Lesions
Yes TR-559 31508-00-6 TEF evaluation (PCB 118) Rats Female Gavage Liver Clear Evidence Cholangiocarcinoma 0/52 0/51 0/52 0/52 3/52 36/49 29/49 adenoma 0/52 1/51 1/52 4/52 12/52 24/49 1/49 hepatocholangioma 0/52 0/51 0/52 0/52 0/52 4/49 0/49 Neoplastic Lesions
Yes TR-560 63-05-8 Androstenedione Mice Female Gavage Liver Clear Evidence Adenoma 14/50 16/50 18/50 28/50 carcinoma 5/50 13/50 15/50 15/50 adenoma or carcinoma 17/50 23/50 27/50 32/50 Neoplastic Lesions
Yes TR-560 63-05-8 Androstenedione Mice Male Gavage Liver Clear Evidence Hepatocellular adenoma, multiple 16/50 27/50 23/50 34/50 hepatocellular adenoma (includes multiples) 32/50 38/50 29/50 43/50 hepatocellular carcinoma multiple 7/50 12/50 10/50 17/50 hepatocellular adenoma or hepatocellular carcinoma (combined includes multiples) 41/50 47/50 42/50 48/50 hepatoblastoma 3/50 8/50 7/50 8/50 hepatocellular adenoma, carcinoma, or hepatoblastoma (combined) 41/50 47/50 43/50 48/50 Neoplastic Lesions
Yes TR-561 119-64-2 Tetralin Rats Female Inhalation Liver Some Evidence Adenoma 0/50 0/50 0/50 3/50 adenoma or carcinoma 0/50 0/50 1/50 4/50 Neoplastic Lesions
Yes TR-562 GOLDENSEALRT Goldenseal root powder Mice Male Dosed-Feed Liver Some Evidence Hepatoblastoma 1/50 2/50 1/5 6/50 multiple adenoma 3/50 5/50 11/50 18/50 Neoplastic Lesions
Yes TR-562 GOLDENSEALRT Goldenseal root powder Rats Female Dosed-Feed Liver Clear Evidence Adenoma: 0/50 0/50 1/50 8/50 Neoplastic Lesions
Yes TR-562 GOLDENSEALRT Goldenseal root powder Rats Male Dosed-Feed Liver Clear Evidence Adenoma: 1/50 1/50 2/50 10/50 adenoma or carcinoma 1/50 1/50 2/50 11/50 Neoplastic Lesions
Yes TR-563 89-82-7 Pulegone Mice Female Gavage Liver Clear Evidence Hepatocellular: Adenoma 13/49 15/50 13/50 27/50 adenoma, carcinoma or hepatoblastoma 17/49 15/50 15/50 33/50 Neoplastic Lesions
Yes TR-563 89-82-7 Pulegone Mice Male Gavage Liver Clear Evidence Hepatocellular: Adenoma 22/50 31/50 35/50 28/50 adenoma, carcinoma, or hepatoblastoma 29/50 37/50 42/50 36/50 Neoplastic Lesions
Yes TR-571 9000-38-8 Kava kava extract Mice Female Gavage Liver Clear Evidence Hepatocellular carcinoma 3/50 13/50 8/50 8/50 hepatocellular adenoma or carcinoma 10/50 21/50 20/50 13/50 Neoplastic Lesions
Yes TR-571 9000-38-8 Kava kava extract Mice Male Gavage Liver Clear Evidence Hepatoblastoma 0/50 4/50 9/50 12/50 Neoplastic Lesions
Yes TR-518 102-71-6 Triethanolamine Mice Female Topical Application Liver Some Evidence ADENOMA 9/50 18/50 20/50 33/50 COMBINED 12/50 23/50 24/50 34/50 Neoplastic Lesions
Yes TR-520 57465-28-8 Toxic equivalency factor evaluation ((PCB 126) 3,3',4,4',5-pentachlorobiphenyl) Rats Female Gavage Liver Clear Evidence CHOLANGIOCARCINOMA 0/53 0/55 1/53 0/53 5/53 6/51 22/53 2/50 OR ADENOMA 1/53 2/55 1/53 0/53 2/53 4/51 7/53 0/50 OR HEPATOCHOLANGIOMA 0/53 0/55 0/53 0/53 0/53 0/51 3/53 0/50 Neoplastic Lesions
Yes TR-521 1746-01-6 TEF evaluation (TCDD) Rats Female Gavage Liver Clear Evidence ADENOMA 0/53 0/54 0/53 0/53 1/53 13/53 2/50 OR CHOLANGIOCARCINOMA 0/53 0/54 0/53 1/53 4/53 25/53 2/50 Neoplastic Lesions
Yes TR-525 57117-31-4 TEF evaluation (PECDF (Pentachlorodibenzofuran)) Rats Female Gavage Liver Some Evidence ADENOMA 1/53 0/53 1/53 0/52 2/53 4/53 1/50 OR CHOLANGIOCARCINOMA 0/53 0/53 0/53 1/52 1/53 2/53 0/50 Neoplastic Lesions
Yes TR-526 TEFDIOXINMIX TEF evaluation (Dioxin mixture) Rats Female Gavage Liver Clear Evidence ADENOMA 0/53 1/53 1/53 1/53 11/51 OR CHOLANGIOCARCINOMA 0/53 0/53 2/53 7/53 9/51 Neoplastic Lesions
Yes TR-527 129-73-7 Leucomalachite green Mice Female Dosed-Feed Liver Some Evidence ADENOMA OR CARCINOMA 3/47 6/48 6/47 11/47 Neoplastic Lesions
Yes TR-528 96-18-4 Fish project 1 (1,2,3-Trichloropropane) Fish Female Aquatic Liver Positive CHOLANGIOCARCINOMA 0/95 29/93 53/94 41/67 ADENOMA 1/95 1/93 5/94 8/67 CARCINOMA 1/95 1/93 2/94 5/67 ADENOMA OR CARCINOMA 2/95 2/93 7/94 13/67 HEPATOCHOLANGIOCARCINOMA 0/95 0/93 4/94 7/67 Neoplastic Lesions
Yes TR-528 96-18-4 Fish project 1 (1,2,3-Trichloropropane) Fish Female Aquatic Liver Positive CHOLANGIOCARCINOMA 1/57 15/44 31/49 21/31 ADENOMA 4/57 2/44 2/49 1/31 CARCINOMA 0/57 2/44 1/49 4/31 ADENOMA OR CARCINOMA 4/57 4/44 2/49 5/31 HEPATOCHOLANGIOCARCINOMA 0/57 0/44 0/49 1/31 Neoplastic Lesions
Yes TR-528 96-18-4 Fish project 1 (1,2,3-Trichloropropane) Fish Female Aquatic Liver Positive CHOLANGIOMA 0/64 3/64 4/47 2/33 CHOLANGIOCARCINOMA 0/64 0/64 0/47 6/33 ADENOMA OR CARCINOMA 5/64 4/64 4/47 8/33 Neoplastic Lesions
Yes TR-528 96-18-4 Fish project 1 (1,2,3-Trichloropropane) Fish Female Aquatic Liver Positive CHOLANGIOMA 2/31 2/31 0/31 2/27 CHOLANGIOCARCINOMA 0/31 0/31 0/31 5/27 ADENOMA OR CARCINOMA 2/31 1/31 2/31 3/27 Neoplastic Lesions
Yes TR-528 96-18-4 Fish project 1 (1,2,3-Trichloropropane) Fish Male Aquatic Liver Positive CHOLANGIOMA 0/42 0/47 3/33 1/46 CHOLANGIOCARCINOMA 0/42 19/47 16/33 26/46 ADENOMA 0/42 1/47 0/33 0/46 ADENOMA OR CARCINOMA 0/42 2/47 0/33 1/46 Neoplastic Lesions
Yes TR-528 96-18-4 Fish project 1 (1,2,3-Trichloropropane) Fish Male Aquatic Liver Positive CHOLANGIOMA 0/95 6/94 2/65 1/78 CHOLANGIOCARCINOMA 0/95 32/94 43/65 45/78 ADENOMA OR CARCINOMA 0/95 2/94 1/65 6/78 HEPATOCHOLANGIOCARCINOMA 0/95 0/94 2/65 6/78 Neoplastic Lesions
Yes TR-528 96-18-4 Fish project 1 (1,2,3-Trichloropropane) Fish Male Aquatic Liver Positive CHOLANGIOCARCINOMA 0/32 0/19 0/26 1/19 ADENOMA 3/32 4/19 5/26 7/19 CARCINOMA 0/32 0/19 1/26 4/19 ADENOMA OR CARCINOMA COMBINED 3/32 4/19 5/26 10/19 Neoplastic Lesions
Yes TR-528 96-18-4 Fish project 1 (1,2,3-Trichloropropane) Fish Male Aquatic Liver Positive CHOLANGIOCARCINOMA 0/61 0/47 0/67 3/27 ADENOMA 3/61 8/47 17/67 9/27 CARCINOMA 0/61 1/47 0/67 7/27 ADENOMA OR CARCINOMA COMBINED 3/61 9/47 17/67 15/27 Neoplastic Lesions
Yes TR-528 3296-90-0 Fish project 1 (2,2-bis(Bromomethyl)-1,3-propanediol) Fish Male Aquatic Liver Positive ADENOMA 1/27 0/21 1/31 3/29 ADENOMA OR CARCINOMA 1/27 0/21 1/31 4/29 Neoplastic Lesions
Yes TR-528 3296-90-0 Fish project 1 (2,2-bis(Bromomethyl)-1,3-propanediol) Fish Male Aquatic Liver Positive ADENOMA 1/47 0/59 0/56 6/59 ADENOMA OR CARCINOMA 1/47 0/59 0/56 8/59 Neoplastic Lesions
Yes TR-528 3296-90-0 Fish project 1 (2,2-bis(Bromomethyl)-1,3-propanediol) Fish Male Aquatic Liver Positive ADENOMA 0/28 3/22 3/21 6/24 ADENOMA OR CARCINOMA 0/28 3/22 3/21 9/24 Neoplastic Lesions
Yes TR-528 3296-90-0 Fish project 1 (2,2-bis(Bromomethyl)-1,3-propanediol) Fish Male Aquatic Liver Positive ADENOMA 3/61 4/50 4/41 8/38 ADENOMA OR CARCINOMA 4/61 6/50 6/41 10/38 Neoplastic Lesions
Yes TR-530 TEFBINARYMIX TEF evaluation (Binary mixture; PCB 126/PCB 153) Rats Female Gavage Liver Clear Evidence CHOLANGIOCARCINOMA 0/53 0/53 1/52 9/52 30/51 HEPATOCHOLANGIOMA 0/53 0/53 0/52 2/52 6/51 ADENOMA 0/53 0/53 3/52 5/52 27/51 Neoplastic Lesions
Yes TR-531 TEFPCBMIX TEF Evaluation (PCB Mixture; PCB 126/PCB 118) Rats Female Gavage Liver Clear Evidence CHOLANGIOCARCINOMA 0/53 0/51 5/53 19/53 28/53 12/65 19/50 ADENOMA 2/53 1/51 0/53 4/53 17/53 5/65 1/50 CARCINOMA 0/53 0/51 0/53 0/53 1/53 0/65 0/50 Neoplastic Lesions
Yes TR-533 119-61-9 Benzophenone Mice Male Dosed-Feed Liver Some Evidence ADENOMA 11/50 15/50 23/50 23/50 ADENOMA, CARCINOMA, OR HEPATOBLASTOMA 18/50 20/50 25/50 29/50 Neoplastic Lesions
Yes TR-537 631-64-1 Water disinfection byproducts (Dibromoacetic acid) Mice Female Dosed-Water Liver Clear Evidence ADENOMA 19/49 26/50 32/50 35/49 CARCINOMA 3/49 3/50 12/50 8/49 COMBINED 22/49 28/50 37/50 37/49 Neoplastic Lesions
Yes TR-537 631-64-1 Water disinfection byproducts (Dibromoacetic acid) Mice Male Dosed-Water Liver Clear Evidence ADENOMA 18/49 37/50 37/50 42/50 CARCINOMA 14/49 9/50 19/50 26/50 COMBINED 28/49 41/50 42/50 47/50 HEPATOBLASTOMA 0/49 4/50 6/50 18/50 Neoplastic Lesions
Yes TR-538 108-10-1 Methyl isobutyl ketone Mice Female Inhalation Liver Some Evidence ADENOMA 13/50 15/50 20/50 23/50 ADENOMA OR CARCINOMA (COMBINED) 17/50 17/50 22/50 27/50 Neoplastic Lesions
Yes TR-538 108-10-1 Methyl isobutyl ketone Mice Male Inhalation Liver Some Evidence ADENOMA 17/50 25/50 23/50 34/50 ADENOMA OR CARCINOMA (COMBINED) 27/50 34/50 28/50 37/50 Neoplastic Lesions
Yes TR-541 75-12-7 Formamide Mice Male Gavage Liver Clear Evidence hemangiosarcoma (1/50, 5/50, 7/50, 8/50) Neoplastic Lesions
Yes TR-542 98-82-8 Cumene Mice Female Inhalation Liver Clear Evidence adenoma (18/50, 23/50, 27/50, 29/50); adenoma or carcinoma (25/50, 26/50, 29/50, 36/50) Neoplastic Lesions
Yes TR-543 98-83-9 alpha-Methylstyrene Mice Female Inhalation Liver Clear Evidence ADENOMA 10/50 20/50 21/50 23/50 CARCINOMA 3/50 9/50 6/50 18/50 ADENOMA OR CARCINOMA 13/50 26/50 24/50 33/50 Neoplastic Lesions
Yes TR-549 5589-96-8 Water disinfection byproducts (Bromochloroacetic acid) Mice Female Dosed-Water Liver Clear Evidence Adenoma 27/50 48/50 44/50 46/50 carcinoma 14/50 23/50 26/50 20/50 adenoma or carcinoma 31/50 49/50 46/50 46/50 Neoplastic Lesions
Yes TR-549 5589-96-8 Water disinfection byproducts (Bromochloroacetic acid) Mice Male Dosed-Water Liver Clear Evidence Adenoma 27/50 40/50 40/50 31/50 carcinoma 19/50 25/50 36/50 45/50 adenoma or carcinoma 34/50 44/50 49/50 49/50 hepatoblastoma 4/50 11/50 28/50 34/50 Neoplastic Lesions
Yes TR-551 97-54-1 Isoeugenol Mice Male Gavage Liver Clear Evidence Adenoma 24/50 35/50 37/50 33/50 carcinoma 8/50 18/50 19/50 18/50 adenoma or carcinoma 28/50 43/50 43/50 43/50 Neoplastic Lesions
Yes TR-580 108-99-6 beta-Picoline Mice Female Dosed-Water Liver Clear Evidence hepatocellular carcinoma 11/49 20/50 26/50 23/50 hepatoblastoma 1/49 3/50 4/50 4/50 Neoplastic Lesions
Yes TR-587 79-94-7 Tetrabromobisphenol A Mice Male Gavage Liver Some Evidence hepatoblastoma 2/50 11/50 8/50 Neoplastic Lesions
Yes TR-589 32534-81-9 Pentabromodiphenyl Oxide (Technical) (DE 71) Rats Male Gavage Liver Clear Evidence hepatocellular adenoma or carcinoma 3/49 2/50 4/50 9/50; hepatocholangioma, hepatocellular adenoma, or hepatocellular carcinoma 3/49 2/50 4/50 11/50 Neoplastic Lesions
Yes TR-589 32534-81-9 Pentabromodiphenyl Oxide (Technical) (DE 71) Rats Female Gavage Liver Clear Evidence cholangiocarcinoma 0/50 0/49 0/50 2/47 hepatocholangioma 0/50 0/49 0/50 8/47 hepatocellular adenoma 3/50 2/49 8/50 16/47 hepatocellular carcinoma 0/50 0/49 1/50 6/47 hepatocellular adenoma or carcinoma 3/50 2/49 8/50 17/47) hepatocholangioma, hepatocellular adenoma, or hepatocellular carcinoma 3/50 2/49 8/50 21/47 Neoplastic Lesions
Yes TR-589 32534-81-9 Pentabromodiphenyl Oxide (Technical) (DE 71) Mice Male Gavage Liver Clear Evidence hepatocellular adenoma 23/50 35/50 49/50 40/50 hepatocellular carcinoma 18/50 15/50 30/50 45/50 hepatocellular adenoma or carcinoma 31/50 40/50 49/50 47/50 hepatoblastoma 1/50 1/50 16/50 5/50 hepatocellular adenoma, hepatocellular carcinoma, or hepatoblastoma 31/50 40/50 49/50 47/50 Neoplastic Lesions
Yes TR-589 32534-81-9 Pentabromodiphenyl Oxide (Technical) (DE 71) Mice Female Gavage Liver Clear Evidence hepatocellular adenoma 5/50 7/49 32/50 46/49 hepatocellular carcinoma 4/50 2/49 6/50 27/49 hepatocellular adenoma or carcinoma 8/50 8/49 33/50 47/49 Neoplastic Lesions
Yes TR-595 CELLPRADCDMA Cell Phone Radiation: CDMA Rats Male Whole Body Exposure Liver Clear Evidence hepatocellular adenoma or carcinoma (combined) (0/90, 2/90, 4/89, 1/88) May Have Been Related
Yes TR-594 98-56-6 p-Chloro-a,a,a-trifluorotoluene Mice Male Inhalation Liver Clear Evidence hepatocellular carcinoma (8/50, 19/50, 16/50, 35/50); hepatoblastoma (1/50, 1/50, 1/50, 15/50) Neoplastic Lesions
Yes TR-594 98-56-6 p-Chloro-a,a,a-trifluorotoluene Mice Female Inhalation Liver Clear Evidence hepatocellular adenoma (12/50, 14/50, 24/50, 34/50); hepatocellular carcinoma (7/50, 8/50, 12/50, 34/50); hepatoblastoma (0/50, 0/50, 1/50, 8/50) Neoplastic Lesions
Yes TR-575 79-06-1 Acrylamide Rats Female Dosed-Water Liver Clear Evidence adenoma 0/48 0/48 1/48 1/48 3/48 Neoplastic Lesions
Yes TR-576 15625-89-5 Trimethylolpropane triacrylate Mice Female Topical Application Liver Some Evidence hepatoblastoma 0/50, 4/50, 0/50, 3/50; hepatocholangiocarcinoma 0/50, 0/50, 1/50, 2/50 Neoplastic Lesions
Yes TR-578 90045-36-6 Ginkgo biloba extract Mice Female Gavage Liver Clear Evidence hepatocellular adenoma 17/50, 37/50, 41/50, 48/50; hepatocellular carcinoma 9/50, 10/50, 15/50, 44/50; hepatoblastoma 1/50, 1/50, 8/50, 11/50 Neoplastic Lesions
Yes TR-578 90045-36-6 Ginkgo biloba extract Mice Male Gavage Liver Clear Evidence hepatocellular carcinoma 22/50, 31/50, 41/50, 47/50; hepatoblastoma 3/50, 28/50, 36/50, 38/50 Neoplastic Lesions
Yes TR-579 99-97-8 N,N-Dimethyl-p-toluidine Mice Female Gavage Liver Clear Evidence hepatocellular adenoma 17/50, 19/50, 37/50, 44/50; hepatocellular carcinoma 6/50, 13/50, 18/50, 31/50; hepatoblastoma 0/50, 1/50, 0/50, 4/50 Neoplastic Lesions
Yes TR-579 99-97-8 N,N-Dimethyl-p-toluidine Mice Male Gavage Liver Clear Evidence hepatocellular adenoma, multiple 17/50, 19/50, 27/50, 26/50; hepatocellular carcinoma 22/50, 25/50, 30/50, 36/50; hepatoblastoma 1/50, 5/50, 10/50, 8/50 Neoplastic Lesions
Yes TR-579 99-97-8 N,N-Dimethyl-p-toluidine Rats Female Gavage Liver Clear Evidence hepatocellular carcinoma 0/50, 0/50, 0/50, 4/49; hepatocellular adenoma or carcinoma 0/50, 1/50, 1/50, 7/49 Neoplastic Lesions
Yes TR-579 99-97-8 N,N-Dimethyl-p-toluidine Rats Male Gavage Liver Clear Evidence hepatocellular carcinoma 0/50, 0/50, 1/50, 6/50; hepatocellular adenoma or carcinoma 0/50, 0/50, 2/50, 6/50 Neoplastic Lesions